NASDAQ:IBRX | Operating Income | ImmunityBio, Inc.

Complete source-backed operating income history.

Available history
2014-06-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$61.7M
2026-03-31-$69.79M
2025-12-31-$64.68M
2025-09-30-$55.63M
2025-06-30-$71.29M
2025-03-31-$64.43M
2024-12-31-$69.4M
2024-09-30-$80.25M
2024-06-30-$99.33M
2024-03-31-$95.2M
2023-12-31-$85.39M
2023-09-30-$80.14M
2023-06-30-$85.15M
2023-03-31-$111.58M
2022-12-31-$84.9M
2022-09-30-$90.8M
2022-06-30-$79.62M
2022-03-31-$95.97M
2021-12-31-$79.27M
2021-09-30-$78.84M
2021-06-30-$85.91M
2021-03-31-$86.26M
2020-12-31-$67.39M
2020-09-30-$65.88M
2020-06-30-$50.92M
2020-03-31-$36.7M
2019-12-31-$104.56M
2019-09-30-$16.07M
2019-06-30-$17.3M
2019-03-31-$18.34M
2018-12-31-$17.72M
2018-09-30-$24.11M
2018-06-30-$28.28M
2018-03-31-$28.28M
2017-12-31-$25.39M
2017-09-30-$24.44M
2017-06-30-$23.82M
2017-03-31-$25.46M
2016-12-31-$25.14M
2016-09-30-$32.78M
2016-06-30-$34.97M
2016-03-31-$31.62M
2015-12-31-$29.92M
2015-09-30-$46.46M
2015-06-30-$130.4M
2015-03-31-$32.1M
2014-12-31-$2.61M
2014-09-30-$897,000.00
2014-06-30-$1.17M

Annual Operating Income

DateOperating Income
2025-12-31-$256.03M
2024-12-31-$344.18M
2023-12-31-$362.25M
2022-12-31-$351.3M
2021-12-31-$330.28M
2020-12-31-$220.88M
2019-12-31-$156.25M
2018-12-31-$98.39M
2017-12-31-$99.12M
2016-12-31-$124.5M
2015-12-31-$238.88M
2014-12-31-$5.58M